179 related articles for article (PubMed ID: 8448603)
1. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.
McMurdo L; Corder R; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Feb; 108(2):557-61. PubMed ID: 8448603
[TBL] [Abstract][Full Text] [Related]
2. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
3. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.
Cristol JP; Warner TD; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):776-9. PubMed ID: 8467364
[TBL] [Abstract][Full Text] [Related]
4. Characterization of endothelin receptors mediating the effects of the endothelin/sarafotoxin peptides on autonomic neurotransmission in the rat vas deferens and guinea-pig ileum.
Warner TD; Allcock GH; Mickley EJ; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):783-9. PubMed ID: 8242252
[TBL] [Abstract][Full Text] [Related]
5. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
6. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
7. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
McMurdo L; Lidbury PS; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat.
Filep JG; Clozel M; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Nov; 113(3):845-52. PubMed ID: 7858876
[TBL] [Abstract][Full Text] [Related]
9. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
10. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat.
Flynn DA; Sargent CA; Brazdil R; Brown TJ; Roach AG
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S219-21. PubMed ID: 8587368
[TBL] [Abstract][Full Text] [Related]
11. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors.
Filep JG; Sirois MG; Földes-Filep E; Rousseau A; Plante GE; Fournier A; Yano M; Sirois P
Br J Pharmacol; 1993 Jul; 109(3):880-6. PubMed ID: 8358577
[TBL] [Abstract][Full Text] [Related]
13. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action.
Poulat P; D'Orléans-Juste P; de Champlain J; Yano M; Couture R
Brain Res; 1994 Jun; 648(2):239-48. PubMed ID: 7522926
[TBL] [Abstract][Full Text] [Related]
15. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
16. Effects of the endothelin (ET) receptor antagonist BQ 123 on initial and delayed vascular responses induced by ET-1 in conscious, normotensive rats.
Bird JE; Waldron TL; Dorso CR; Asaad MM
J Cardiovasc Pharmacol; 1993 Jul; 22(1):69-73. PubMed ID: 7690099
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
Cirino M; Martin E; Yano M; Rodger IW
J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.
Bigaud M; Pelton JT
Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature.
Moreland S; McMullen D; Abboa-Offei B; Seymour A
Br J Pharmacol; 1994 Jun; 112(2):704-8. PubMed ID: 8075891
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-B receptor-dependent modulation of the pressor and prostacyclin-releasing properties of dynamically converted big endothelin-1 in the anesthetized rabbit.
Gratton JP; Cournoyer G; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S161-3. PubMed ID: 9595427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
